NYSE · LLY
Eli Lilly and Company
$1,427.51+$53.81 (+3.92%)
Eli Lilly and Company’s quoted price is above the reported 52-week high. The range and quote may have different update times.
Loading market information…
KOE · 950220.KQ · KRW
Stock price
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
NeoImmuneTech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.92% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,427.51+$53.81 (+3.92%)
Eli Lilly and Company’s quoted price is above the reported 52-week high. The range and quote may have different update times.
$277.54+$2.34 (+0.85%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 1.17% below the high.
$294.85+$4.06 (+1.4%)
AbbVie Inc.’s quoted price is above the reported 52-week high. The range and quote may have different update times.
$149.26+$2.93 (+2.0%)
Merck & Co., Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.83% below the high.
$409.65-$1.26 (-0.31%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 11.38% below the high.
$702.66-$6.52 (-0.92%)
Thermo Fisher Scientific Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.68% below the high.
$470.30+$9.57 (+2.08%)
Amgen Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
$172.09+$6.48 (+3.91%)
Gilead Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.99% below the high.
